Friday

7th Aug 2020

Coronavirus

EU science chief who 'quit' had been told to resign

  • Mauro Ferrari (l) dramatically resigned on Tuesday as president of the EU's top science funding agency, amid the global coronavirus pandemic (Photo: EC - Audiovisual Service)

The shock resignation of Mauro Ferrari as president of EU's top science-funding agency in fact followed a vote of no confidence by his peers, it emerged on Wednesday (8 April).

After only three months on the job, Ferrari dramatically quit as head of the European Research Council (ERC) on Tuesday (7 April), complaining of internal disputes on how to best tackle the pandemic.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

But on Wednesday, 24 hours later, the scientific council overseeing the ERC said they in fact had all wanted him gone already at the end of March.

The resignation made immediate headlines globally, after Ferrari published a long statement in the Financial Times, outlining his disillusionment with the European Union.

Ferrari had sought to establish a special programme within the ERC to combat the virus. The proposal was rejected by the ERC's scientific council.

"The rejection of my motion was based on the notion that the ERC funds 'bottom-up' research," said Ferrari, noting that European Commission president Ursula von der Leyen had also personally reached out to him.

Ferrari said he then put together a plan, with von der Leyen's input, but it quickly dissolved within the administrative machinery of the European Commission.

"I have been extremely disappointed by the European response to Covid-19," he said, adding that his work with von der Leyen had created an internal political firestorm.

But this version of events leading to his resignation and von der Leyen's personal appeals to him have since been contested.

The European Commission's chief spokesperson, Eric Mamer, stepped into the fray on Wednesday, after telling reporters that Ferrari was wrong.

"It is professor Ferrari who reached out to the president. President von der Leyen did not solicit any proposals from professor Ferrari," Mamer told reporters in Brussels at the daily midday briefing.

The ERC's scientific council also hit back only moments later, bullet-pointing all their complaints against Ferrari, while insinuating he had been lying.

"We regret professor Ferrari's statement, which at best is economical with the truth," they said.

They further claim Ferrari had, during his three-month tenure, "displayed a complete lack of appreciation" for the ERC's role, that he spent way too much time in the United States, bypassed the ERC by going straight to the commission, and had too many other academic and commercial interests.

He is, for instance, listed on the board of directors at US biotech company Arrowhead Pharmaceuticals.

The European Research Council itself is appointed by the European Commission. One of ERC's vice-presidents has since taken over Ferrari's leadership role until a new president is found.

The ERC was founded in 2007 and has a €13bn budget spanning seven years.

Journalism hit hard by corona crisis

An already fragile business model for journalism might be dealt a lethal blow in the corona crisis. And the freedom of the press itself is coming under extreme pressure, as governments take swift and debilitating measures fighting the pandemic.

Roma 'at heightened risk' from corona crisis

The EU's Agency for Fundamental Rights has warned that Roma inequality and discrimination is growing due to the coronavirus outbreak. Meanwhile, the EU Commission will present a strategy for Roma equality to tackle discrimination.

Analysis

How the EU's virus-alert agency failed

The European Centre for Disease Prevention and Control, an EU agency, was meant to highlight threats from infectious diseases, but painted a rosy picture of Covid-19.

EU secures remdesivir supplies for 30,000 patients

The European Commission signed this week a €63m contract with the US-based biopharmaceutical company Gilead to secure batches of remdesivir for 30,000 patients with "severe" Covid-19 symptoms - after the US left Europe and most of the world without supplies.

News in Brief

  1. Germany breached rights of Madeleine McCann suspect
  2. EU offers trade perks to Lebanon
  3. Germany charges four ex-Audi chiefs on emissions cheating
  4. UK quarantines Belgium, as European infections climb
  5. Bulgaria's Borissov mulls resignation
  6. EU prolongs anti-dumping duties on Chinese steel
  7. Swedish economy contracted less during April to June
  8. EU offers help to Lebanon after port explosion

Opinion

Italy has a responsibility, too

Little wonder the leaders of Austria, Denmark, the Netherlands and Sweden are unwilling to sign off: they're not going to give money so the Italians can fund a tax cut in the middle of an economic crisis.

Stakeholders' Highlights

  1. UNESDANext generation Europe should be green and circular
  2. Nordic Council of MinistersNEW REPORT: Eight in ten people are concerned about climate change
  3. UNESDAHow reducing sugar and calories in soft drinks makes the healthier choice the easy choice
  4. Nordic Council of MinistersGreen energy to power Nordic start after Covid-19
  5. European Sustainable Energy WeekThis year’s EU Sustainable Energy Week (EUSEW) will be held digitally!
  6. Nordic Council of MinistersNordic states are fighting to protect gender equality during corona crisis

Latest News

  1. Iraqis paid €2,000 each agree to leave Greece
  2. EU's most sustainable islands are Danish 'Sunshine Islands'
  3. Worrying rows over future EU chemicals policy
  4. Rainbow flag protesters charged by Polish police
  5. An open letter to the EPP on end of Hungary's press freedom
  6. Renew Europe has a plan to combat gender-violence
  7. Why EU beats US on green pandemic recovery
  8. Azerbaijan ambassador to EU shared anti-George Floyd post

Join EUobserver

Support quality EU news

Join us